Clinical Trial: A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07657052) titled 'A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria' on May 29.

Brief Summary: This is a multicenter, open-label study to evaluate the long-term safety and efficacy of XH-S003 capsules in PNH patients. About 26 PNH patients who had received and completed XH-S003 study treatment will be enrolled to take XH-S003 capsules orally according to protocol. Eligible subjects can maintain XH-S003 treatment until the end of the study.

Study Start Date: Aug. 15, 2025

Study Type: INTERVENTIONAL

Condition: Paroxysmal Nocturnal Hemoglobinuria

Int...